KommentarOpen Access
Genetic Screening, Cancer Syndromes, and the Radiologist
Radiology: Imaging Cancer · 2024
DOI: 10.1148/rycan.240045 ↗Kurz gefasst
Kommentar in der Zeitschrift Radiology: Imaging Cancer, 2024. Verfasst von Peter L Choyke. Beteiligte Einrichtung: From the Molecular Imaging Branch, National Cancer Institute, 10 Center Dr, Bldg 10, Room B3B69F, Bethesda, MD 20892. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Kidney Neoplasms. Die Arbeit nennt 9 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Carcinoma, Renal CellKidney NeoplasmsHumansEarly Detection of CancerPrevalenceGerm-Line MutationRadiologistsGenetic TestingProto-Oncogene ProteinsTumor Suppressor ProteinsUbiquitin Thiolesterase
Substanzen
FLCN protein, humanProto-Oncogene ProteinsTumor Suppressor ProteinsBAP1 protein, humanUbiquitin Thiolesterase
Autor:innen und Institutionen
- From the Molecular Imaging Branch, National Cancer Institute, 10 Center Dr, Bldg 10, Room B3B69F, Bethesda, MD 20892.
ORCID-Profile: Peter L Choyke
Zitieren
APA
Choyke, P. L. (2024). Genetic Screening, Cancer Syndromes, and the Radiologist. Radiology: Imaging Cancer. https://doi.org/10.1148/rycan.240045
Vancouver
Choyke PL. Genetic Screening, Cancer Syndromes, and the Radiologist. Radiology: Imaging Cancer. 2024. doi:10.1148/rycan.240045
BibTeX
@article{Choyke2024,
author = {Choyke, Peter L},
title = {Genetic Screening, Cancer Syndromes, and the Radiologist},
journal = {Radiology: Imaging Cancer},
year = {2024},
doi = {10.1148/rycan.240045}
}
EUVIMED